S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 SurModicsMiMedx GroupAntares PharmaOrthopediatricsIntersect ENT
SymbolNASDAQ:SRDXOTCMKTS:MDXGNASDAQ:ATRSNASDAQ:KIDSNASDAQ:XENT
Price Information
Current Price$44.12$5.08$3.43$36.10$17.74
52 Week RangeBuyN/ABuyBuyHold
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyHold
Consensus Price Target$69.00N/A$5.04$47.00$26.46
% Upside from Price Target56.39% upsideN/A46.79% upside30.19% upside49.15% upside
Trade Information
Market Cap$604.78 million$406.41 million$564.19 million$537.68 million$529.06 million
Beta1.080.780.820.210.72
Average Volume104,985610,062968,91575,796379,698
Sales & Book Value
Annual Revenue$81.34 million$245.01 million$63.55 million$57.56 million$108.47 million
Price / Sales7.322.308.809.375.15
Cashflow$0.97 per shareN/AN/AN/AN/A
Price / Cash45.47N/AN/AN/AN/A
Book Value$8.13 per shareN/A$0.25 per share$6.38 per share$3.96 per share
Price / Book5.4313.725.664.48
Profitability
Net Income$-4,450,000.00$11.97 million$-6,510,000.00$-12,020,000.00$-22,920,000.00
EPS$0.49N/A($0.04)($0.96)($0.76)
Trailing P/E Ratio90.040.00N/AN/AN/A
Forward P/E Ratio77.4021.44N/AN/A
P/E Growth$7.86N/AN/AN/AN/A
Net Margins2.48%N/A-4.03%-15.77%-31.43%
Return on Equity (ROE)4.87%N/A-9.67%-12.92%-29.16%
Return on Assets (ROA)3.61%N/A-3.85%-8.30%-25.24%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A1.01%0.24%N/A
Current Ratio4.04%N/A3.46%2.53%7.94%
Quick Ratio3.80%N/A2.87%1.75%6.96%
Ownership Information
Institutional Ownership Percentage89.53%1.32%38.72%49.38%96.29%
Insider Ownership Percentage6.30%12.40%5.49%40.70%6.50%
Miscellaneous
Employees338N/A16580393
Shares Outstanding13.49 million111.04 million163.06 million14.94 million31.47 million
Next Earnings Date11/8/2019 (Estimated)N/A11/5/2019 (Estimated)10/30/2019 (Estimated)11/1/2019 (Confirmed)
OptionableOptionableOptionableOptionableNot OptionableOptionable
 SurModicsMiMedx GroupAntares PharmaOrthopediatricsIntersect ENT

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel